Appointment of Ajay P Patel as Chief Financial officer of the Company

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+16.3%Reaction day

₹40.00

prior close

₹44.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+15.7% vs market

Commodity Chemicals peers, median of 53sector+0.8%+15.4% vs sector

On the reaction day the stock moved 15.7 pts more than Nifty Microcap 250 and 15.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.6

10m

+1.6

15m

+2.7

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+16.3+0.6+15.7+0.8+15.4

Next day

+12.5+0.5+12.0+0.8+11.7

+11.7+0.8+10.9+0.6+11.1

+7.5+1.2+6.3+0.2+7.3

+6.8+1.5+5.4-0.0+6.9

+8.6+1.6+7.1+1.1+7.5

+12.5+1.8+10.7-0.1+12.6

15d

+12.5+3.3+9.2+1.0+11.4

+7.5+3.1+4.4+2.4+5.1

+6.3+2.3+4.0-0.0+6.3

+12.5+0.2+12.3-4.4+16.9

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Archit Organosys Ltd has appointed Mr. Ajay Punamchand Patel as its new Chief Financial Officer (Key Managerial Personnel), effective 23rd May 2025. The appointment was approved by the Board of Directors at its meeting held on the same day. Mr. Patel holds over 7 years of experience in accounting, auditing, fund management, and direct and indirect taxation, and has already been associated with the company for some time. The company has also updated the contact details of its Key Managerial Personnel for stock exchange disclosures.

Likely market impact

This is a routine leadership change at the CFO level with no negative implications indicated. Shareholders should note the appointment may bring continuity since Mr. Patel is already familiar with the company's operations. No material impact on stock price is expected.